Cargando…
Letter 2 regarding “Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma”
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Korean Association for the Study of the Liver
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10366795/ https://www.ncbi.nlm.nih.gov/pubmed/37221834 http://dx.doi.org/10.3350/cmh.2023.0170 |
| _version_ | 1785077247747555328 |
|---|---|
| author | Kleebayoon, Amnuay Wiwanitkit, Viroj |
| author_facet | Kleebayoon, Amnuay Wiwanitkit, Viroj |
| author_sort | Kleebayoon, Amnuay |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10366795 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | The Korean Association for the Study of the Liver |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-103667952023-07-26 Letter 2 regarding “Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma” Kleebayoon, Amnuay Wiwanitkit, Viroj Clin Mol Hepatol Letter to the Editor The Korean Association for the Study of the Liver 2023-07 2023-05-24 /pmc/articles/PMC10366795/ /pubmed/37221834 http://dx.doi.org/10.3350/cmh.2023.0170 Text en Copyright © 2023 by The Korean Association for the Study of the Liver https://creativecommons.org/licenses/by-nc/3.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letter to the Editor Kleebayoon, Amnuay Wiwanitkit, Viroj Letter 2 regarding “Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma” |
| title | Letter 2 regarding “Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma” |
| title_full | Letter 2 regarding “Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma” |
| title_fullStr | Letter 2 regarding “Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma” |
| title_full_unstemmed | Letter 2 regarding “Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma” |
| title_short | Letter 2 regarding “Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma” |
| title_sort | letter 2 regarding “assessing the performance of chatgpt in answering questions regarding cirrhosis and hepatocellular carcinoma” |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10366795/ https://www.ncbi.nlm.nih.gov/pubmed/37221834 http://dx.doi.org/10.3350/cmh.2023.0170 |
| work_keys_str_mv | AT kleebayoonamnuay letter2regardingassessingtheperformanceofchatgptinansweringquestionsregardingcirrhosisandhepatocellularcarcinoma AT wiwanitkitviroj letter2regardingassessingtheperformanceofchatgptinansweringquestionsregardingcirrhosisandhepatocellularcarcinoma |